Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hib-DTP-hepatitis B vaccine (Easyfive-TT) - Panacea Biotec

Next Previous
X
Search
Drug Profile

Hib-DTP-hepatitis B vaccine (Easyfive-TT) - Panacea Biotec

Alternative Names: DTwP-HepB-Hib vaccine - Panacea Biotec; Easy-five; Easyfive-TT; My Five; Pentavalent vaccine - Panacea Biotec

Latest Information Update: 20 Apr 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Panacea Biotec
  • Class Bacterial vaccines; Conjugate vaccines; Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 20 Apr 2022 Discontinued - Phase-III for Diphtheria (Prevention) in Thailand, Egypt, Chile (IM)
  • 20 Apr 2022 Discontinued - Phase-III for Haemophilus infections (Prevention) in Chile, Thailand, Egypt (IM)
  • 20 Apr 2022 Discontinued - Phase-III for Hepatitis B (Prevention) in Chile, Thailand, Egypt (IM)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top